Sugujin Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 3 Months 3 Days
About Sugujin Diagnostics
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Maheshkumar Parmar, Hardik Savani, Nilay Bakriwala, and Three other members serve as directors at the Company.
- CIN/LLPIN
U46596GJ2024PTC155823
- Company No.
155823
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Oct 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sugujin Diagnostics?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Maheshkumar Parmar | Director | 17-Oct-2024 | Current |
| Hardik Savani | Director | 17-Oct-2024 | Current |
| Nilay Bakriwala | Director | 17-Oct-2024 | Current |
Hasmukhkumar Balar  | Director | 17-Oct-2024 | Current |
| Dharmesh Vaghasiya | Director | 17-Oct-2024 | Current |
| Jasvinbhai Kunjadiya | Director | 17-Oct-2024 | Current |
Financial Performance of Sugujin Diagnostics.
Enhance accessibility to Sugujin Diagnostics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Sugujin Diagnostics?
Unlock access to Sugujin Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sugujin Private LimitedActive 2 years 10 monthsHasmukhkumar Balar, Dharmesh Vaghasiya and 1 more are mutual person
- Shc Healthcare Private LimitedActive 2 years 10 months
Hasmukhkumar Balar and Dharmesh Vaghasiya are mutual person
- Bci Healthcare Private LimitedActive 1 year 5 months
Hasmukhkumar Balar and Dharmesh Vaghasiya are mutual person
- Sorus Laboratories (India) Private LimitedActive 1 year 7 months
Dharmesh Vaghasiya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sugujin Diagnostics?
Unlock and access historical data on people associated with Sugujin Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sugujin Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sugujin Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.